Skip to main content
HeartRhythm Case Reports logoLink to HeartRhythm Case Reports
. 2020 Jul 22;6(10):749–753. doi: 10.1016/j.hrcr.2020.07.012

Junctional rhythm following transcatheter aortic valve replacement

Natthapon Angsubhakorn ∗,†,, Baris Akdemir ∗,, Stefan Bertog ∗,, Santiago Garcia , Wasawat Vutthikraivit §, Selcuk Adabag ∗,
PMCID: PMC7573371  PMID: 33101947

Introduction

Transcatheter aortic valve replacement (TAVR) has rapidly evolved as a treatment alternative to surgical aortic valve replacement for patients with symptomatic severe aortic stenosis with moderate or high surgical risk.1,2 With the recent FDA decision to expand its indication to low-risk patients, TAVR is expected to be the primary option for aortic valve replacement in the future.3 However, TAVR is associated with injury to the conduction system at the level of the bundle of His and the left bundle branch, leading to permanent pacemaker (PPM) implantation for complete atrioventricular (AV) block.4 Retrospective data from a large registry of TAVR patients show that procedure-related AV block leading to PPM implantation occurs in up to 12% of patients and has been associated with longer hospital stay and a higher risk of rehospitalization.4, 5, 6, 7, 8 Therefore, efforts to understand the mechanisms and to identify risk factors for post-TAVR AV block should be emphasized.

Junctional rhythm is a common electrocardiogram (ECG) finding in an early postoperative period after cardiac surgery, especially valve replacement, and has been associated with increased morbidity.9 Accelerated junctional rhythm during ablation close to the AV junction is a harbinger of imminent complete AV block. However, the data on junctional rhythm following TAVR are scarce.10 Our case series describes the characteristics and outcomes of 6 patients who developed junctional rhythm after TAVR at a large, urban tertiary care hospital.

Key Teaching Points.

  • Transcatheter aortic valve replacement (TAVR) is associated with injury to the cardiac conduction system. To our knowledge, this is the first case series to describe junctional rhythm as one of the rhythm disorders after TAVR.

  • The mechanism of junctional rhythm after TAVR is not well understood. Enhanced automaticity caused by a pressure-related injury to the atrioventricular nodal region may be responsible for the development of accelerated junctional rhythm in these cases.

  • Although the incidence of sustained junctional rhythm following TAVR is low, its development may be a risk factor associated with adverse outcomes, with 33% of patients in our case series requiring permanent pacemaker (PPM). Whether junctional rhythm is a predictor of patients who would potentially require PPM post TAVR remains unclear and needs further study in larger cohorts.

Case report

Identification of eligible cases

We performed a retrospective chart review of 301 consecutive patients with severe aortic stenosis who underwent TAVR at Minneapolis Veterans Affairs Medical Center from April 2015 through April 2019. Patients who developed new junctional rhythm on post-TAVR 12-lead ECG were included in the case series. The ECGs were independently reviewed by 2 investigators (N.A. and B.A.). The diagnosis of junctional rhythm was established on the basis of ECG finding of regular QRS complexes, not preceded by a P wave. Relevant prespecified characteristics and outcomes of each patient were abstracted from the electronic medical records. This study was approved by the Minneapolis Veterans Affairs Medical Center Institutional Review Board and the individual consent requirement was waived.

Case description

Among 301 consecutive patients who underwent TAVR, 6 patients (2%) had junctional rhythm on post-TAVR 12-lead ECG (Figure 1). The patients had a mean age of 70.2 ± 5.8 years and 83.3% were men. All 6 patients had sinus rhythm at baseline. Pre-existing right bundle branch block (RBBB) was present in 1 patient. No patient had a baseline PR interval >200 ms.

Figure 1.

Figure 1

Junctional rhythm following transcatheter aortic valve replacement. A: A baseline 12-lead electrocardiogram of case 2 was recorded before transcatheter aortic valve replacement (TAVR), demonstrating normal sinus rhythm. B: On post-TAVR day 0, a repeat 12-lead electrocardiogram of case 2 was obtained, which demonstrated accelerated junctional rhythm with a ventricular rate of 83 beats per minute and nonspecific T-wave inversions in the inferolateral leads.

All 6 patients developed junctional rhythm on post-TAVR day 0. In 3 patients (cases 2, 3, and 6), junctional rhythm continued into days 1 and 2. The mean ventricular rate during junctional rhythm was 68.2 ± 12.1 beats per minute. Of the 6 patients, 4 (67%) had accelerated junctional rhythm (ventricular rate >60 beats/min). Five patients (83.3%) had TAVR with a SAPIEN 3 balloon-expandable valve while 1 (16.7%) had an Evolut R self-expandable valve.

In 2 patients (cases 2 and 5), junctional rhythm was accompanied by nonspecific ST-segment or T-wave abnormalities without change in QRS complex morphology. However, neither had chest discomfort or diagnostic regional wall motion abnormality on transthoracic echocardiogram post TAVR. From preprocedural coronary angiogram, case 2 had known chronic total occlusion of the right coronary artery, while case 5 had nonobstructive coronary artery disease.

A permanent dual-chamber pacemaker was implanted in 2 (33%) patients (cases 3 and 6) for complete AV block on post-TAVR days 5 and 1, respectively. This rate is higher than the overall incidence of PPM implantation in our cohort of 301 patients, which is 22.0%, although this does not yield statistical significance owing to the low number of patients in the junctional cohort. At 1 year follow-up, these 2 patients had 8% and 87.5% ventricular pacing, respectively.

In case 3, junctional rhythm spontaneously converted to sinus rhythm before the patient was discharged on post-TAVR day 1. RBBB and normal PR interval were observed. The patient was subsequently rehospitalized for complete AV block with left bundle branch block requiring PPM implantation on post-TAVR day 5. On the other hand, in case 6, junctional rhythm did not return to sinus rhythm. Baseline RBBB and left anterior fascicular block were observed on postprocedural ECG. Ultimately, PPM was implanted on post-TAVR day 1. Neither patient required temporary pacing owing to hemodynamic stability during junctional rhythm.

Two (33%) patients (cases 1 and 2), died during follow-up, 11 days and 34 months post TAVR, respectively. In patients without junctional rhythm following TAVR in our entire cohort, the 1-month and 1-year mortality rates were 2.4%, and 15.3%, respectively. The cause of death in case 1 was pulseless electrical activity, which occurred 11 days post TAVR; an autopsy was performed but the cause remained unrevealed. The cardiac rhythm was sinus before death. The cause of death in case 2 was unknown.

Characteristics and outcomes of patients with post-TAVR junctional rhythm are summarized in Table 1.

Table 1.

Characteristics and outcomes of patients who developed post–transcatheter aortic valve replacement (junctional rhythm)

Case 1 Case 2 Case 3 Case 4 Case 5 Case 6
Type of valve SAPIEN 3 SAPIEN 3 SAPIEN 3 Evolut R SAPIEN 3 SAPIEN 3
Valve size 26 mm 26 mm 29 mm 34 mm 26 mm 29 mm
Route of access TAo TF TF TF TF TF
Baseline characteristics
 Age (years) 67 62 71 68 81 72
 Sex F M M M M M
 Aortic valve area (cm2) 0.85 0.8 0.59 0.93 0.52 0.99
 Mean aortic gradient (mm Hg) 52 26 50 39 37.5 40
 LVEF (%) 50 20–25 60–65 55 55–65 55
 CAD Yes Yes Yes Yes Yes Yes
 Prior CABG No No Yes Yes No No
 Beta-blocker use No Yes No Yes Yes No
 Serum sodium (mEq/L) 139 139 144 133 141 141
 Serum potassium (mEq/L) 3.0 4.0 4.4 3.9 4.3 4.7
 Serum magnesium (mEq/L) 2.1 2.0 2.4 2.5 2.3 2.2
 Baseline ECG rhythm Sinus Sinus Sinus Sinus Sinus Sinus
 Baseline PR interval (ms) 200 200 158 160 158 192
 Baseline QRS interval (ms) 90 126 106 82 84 166
 Baseline bundle branch block No No No No No Yes (RBBB)
Postprocedural ECG
 Rate of junctional rhythm (beats/min) 84 83 70 52 58 62
 Postprocedural day of detection Day 0 Day 0 Day 0 Day 0 Day 0 Day 0
 Presence of bundle branch block No No Yes (RBBB) Yes (LBBB) No Yes (RBBB)
 QRS interval (ms) 88 118 152 152 108 164
Outcomes
 Mortality Died 11 days after TAVR Died 34 months after TAVR Alive Alive Alive Alive
 Postprocedural PPM No No Yes (5 days after TAVR) No No Yes (1 day after TAVR)

CABG = coronary artery bypass grafting; CAD = coronary artery disease; ECG = electrocardiography; LBBB = left bundle branch block; LVEF = left ventricular ejection fraction; PPM = permanent pacemaker; RBBB = right bundle branch block; Tao = transaortic; TAVR = transcatheter aortic valve replacement; TF = transfemoral.

Discussion

Among 301 patients undergoing TAVR at our institution, we found 6 (2%) who developed sustained junctional rhythm on 12-lead ECG following TAVR. Of these, 2 (33%) developed complete AV block requiring PPM implantation, and another 2 (33%) died. These are novel observations of a new rhythm disorder after TAVR.

Several mechanical and electrophysiological risk factors for post-TAVR complete AV block have been identified thus far. Low depth of implantation of the valve into the left ventricular outflow tract, greater prosthesis–to–left ventricular outflow tract ratio, pre-existing RBBB or AV block, and postprocedural development of left bundle branch block are some of these risk factors.6,10,11 Our observations in this case series suggest that post-TAVR junctional rhythm may also be a risk factor associated with adverse outcomes.

Whether post-TAVR accelerated junctional rhythm requires any treatment beyond supportive care is largely unknown. In our case series, all patients were hemodynamically stable during junctional rhythm. PPM was ultimately implanted in 33% of patients. The clinical course of cases 3 and 6 suggests that post-TAVR junctional rhythm might be related to the development of AV block.

In these cases, the junctional rhythm, captured on 12-lead ECG, was sustained. However, some patients may develop transient junctional rhythm during the inflation of the valve. The prevalence of transient junctional rhythm during TAVR is unknown, and it may be challenging to identify these transient arrhythmias during the procedure. Further, the clinical implications of transient junctional rhythm are unknown and require further study.

The mechanism of junctional rhythm after TAVR is not clearly understood. Lessons from pediatric literature suggest that procedures that involve either manipulation of the AV node, such as ventricular septal defect repair, or pressure on that area, such as from cardiopulmonary bypass cannulation, can lead to enhanced cardiac automaticity and subsequent junctional tachycardia.12 As of this moment, the mechanism of accelerated junctional rhythm after TAVR is unknown. However, it is possible to speculate that mechanical pressure applied by the valve on the AV node may be responsible for the development of accelerated junctional rhythm. Coexisting sinus node dysfunction in this older population may also play a role. More investigation is needed to uncover the mechanisms behind our observations.

Although cardiac surgery has been associated with the development of complications including AV block and need of PPM implantation, remarkably, the rate of PPM after TAVR is twice as high as that following surgical aortic valve replacement (12% vs 6%).4,13, 14, 15 As TAVR is expected to be the predominant treatment modality for aortic valve replacement, it becomes increasingly important to identify patients at risk for PPM implantation. Whether accelerated junctional rhythm should be regarded as an early sign of conduction system injury, a predictor of subsequent AV block, or an indication for PPM in high-risk patients remains unclear and needs further study in larger cohorts. The optimal management strategy in patients with sustained junctional rhythm following TAVR is an important clinical question. Larger observational studies are urgently required to determine the clinical significance of this arrhythmia following TAVR.

Conclusions

Cardiac conduction system disturbances remain among the most frequent complications of TAVR. To our knowledge, this is the first case series to describe post-TAVR junctional rhythm. Post-TAVR junctional rhythm may help clue us in on an earlier diagnosis of high-degree AV block. The mechanisms and implications of this newly described arrhythmia after TAVR need further study.

Footnotes

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. The authors have the following declarations of interest: Dr Stefan Bertog: reimbursement for case proctoring, Edwards Lifesciences; Dr Santiago Garcia: honoraria (modest), Medtronic and Edwards Lifesciences; Dr Selcuk Adabag: research grant; American Heart Association and Medtronic, unrelated to this topic. The rest of the authors have no conflict of interest to disclose.

References

  • 1.Nishimura R.A., Otto C.M., Bonow R.O. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2017;70:252–289. doi: 10.1016/j.jacc.2017.03.011. [DOI] [PubMed] [Google Scholar]
  • 2.Garcia S., Kelly R., Mbai M. Outcomes of intermediate-risk patients treated with transcatheter and surgical aortic valve replacement in the Veterans Affairs Healthcare System: A single center 20-year experience. Catheter Cardiovasc Interv. 2018;92:390–398. doi: 10.1002/ccd.27478. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Mack M.J., Leon M.B., Thourani V.H. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med. 2019;380:1695–1705. doi: 10.1056/NEJMoa1814052. [DOI] [PubMed] [Google Scholar]
  • 4.Grover F.L., Vemulapalli S., Carroll J.D. 2016 annual report of the Society of Thoracic Surgeons/American College of Cardiology transcatheter valve therapy registry. J Am Coll Cardiol. 2017;69:1215–1230. doi: 10.1016/j.jacc.2016.11.033. [DOI] [PubMed] [Google Scholar]
  • 5.Khatri P.J., Webb J.G., Rodés-Cabau J. Adverse effects associated with transcatheter aortic valve implantation: a meta-analysis of contemporary studies. Ann Intern Med. 2013;158:35–46. doi: 10.7326/0003-4819-158-1-201301010-00007. [DOI] [PubMed] [Google Scholar]
  • 6.Nazif T.M., Dizon J.M., Hahn R.T. Predictors and clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve replacement: the PARTNER (Placement of AoRtic TraNscathetER Valves) trial and registry. JACC Cardiovasc Interv. 2015;8:60–69. doi: 10.1016/j.jcin.2014.07.022. [DOI] [PubMed] [Google Scholar]
  • 7.Oestreich B., Gurevich S., Adabag S. Exposure to glucocorticoids prior to transcatheter aortic valve replacement is associated with reduced incidence of high-degree AV block and pacemaker. Cardiovasc Revasc Med. 2019;20:328–331. doi: 10.1016/j.carrev.2018.07.012. [DOI] [PubMed] [Google Scholar]
  • 8.Oestreich B.A., Mbai M., Gurevich S. Computed tomography (CT) assessment of the membranous septal anatomy prior to transcatheter aortic valve replacement (TAVR) with the balloon-expandable SAPIEN 3 valve. Cardiovasc Revasc Med. 2018;19:626–631. doi: 10.1016/j.carrev.2017.12.012. [DOI] [PubMed] [Google Scholar]
  • 9.Kerr C.R., Mason M.A. Incidence and clinical significance of accelerated junctional rhythm following open heart surgery. Am Heart J. 1985;110:966–969. doi: 10.1016/0002-8703(85)90193-0. [DOI] [PubMed] [Google Scholar]
  • 10.Mangieri A., Lanzillo G., Bertoldi L. Predictors of advanced conduction disturbances requiring a late (≥ 48 h) permanent pacemaker following transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2018;11:1519–1526. doi: 10.1016/j.jcin.2018.06.014. [DOI] [PubMed] [Google Scholar]
  • 11.Coumbe A.G., Naksuk N., Newell M.C., Somasundaram P.E., Benditt D.G., Adabag S. Long-term follow-up of older patients with Mobitz type I second degree atrioventricular block. Heart. 2013;99:334–338. doi: 10.1136/heartjnl-2012-302770. [DOI] [PubMed] [Google Scholar]
  • 12.Cools E., Missant C. Junctional ectopic tachycardia after congenital heart surgery. Acta Anaesthesiol Belg. 2014;65:1–8. [PubMed] [Google Scholar]
  • 13.Garcia S., Ko B., Adabag S. Contrast-induced nephropathy and risk of acute kidney injury and mortality after cardiac operations. Ann Thorac Surg. 2012;94:772–776. doi: 10.1016/j.athoracsur.2012.04.089. [DOI] [PubMed] [Google Scholar]
  • 14.Jain R., Duval S., Adabag S. How accurate is the eyeball test? A comparison of physician’s subjective assessment versus statistical methods in estimating mortality risk after cardiac surgery. Circ Cardiovasc Qual Outcomes. 2014;7:151–156. doi: 10.1161/CIRCOUTCOMES.113.000329. [DOI] [PubMed] [Google Scholar]
  • 15.Raza S.S., Li J.M., John R. Long-term mortality and pacing outcomes of patients with permanent pacemaker implantation after cardiac surgery. Pacing Clin Electrophysiol. 2011;34:331–338. doi: 10.1111/j.1540-8159.2010.02972.x. [DOI] [PubMed] [Google Scholar]

Articles from HeartRhythm Case Reports are provided here courtesy of Elsevier

RESOURCES